Insights
Zeynep Seda Alhas Contributed to “Reputed Trade Marks and Their Protection” by Wolters Kluwer
Our Partner Zeynep Seda Alhas contributed to the recently published book “Reputed Trade Marks and Their Protection”, upon the invitation of AIPPI.… »
Insurance Litigation 2026 in Turkey
Legal and procedural framework Legal framework What legal framework applies to insurance coverage disputes, including legislation or judicial precedents? 08 December 2025Insurance coverage disputes in Türkiye are primarily governed by the Turkish Commercial Code (Law No. 6102) (TCC) (articles 1401to1520) and the Insurance Act (Law No. 5684), which regulate insurance contracts, coverage limits, exclusions, duties of disclosure and the authority of the Insurance Arbitration… »
The Silent Crisis in Trademark Law: Inconsistencies in Actions for the Cancellation of Higher Board Decisions
Actions brought against decisions rendered by the Re-Examination and Evaluation Board (“Higher Board”) concerning trademark applications constitute an important part of Turkish trademark law practice. In practice, particularly in actions brought following the refusal of an opposition filed by the owner of an earlier trademark, it is common for plaintiffs to seek not only the cancellation of the Higher Board decision but also the invalidation of the trademark at issue if it is… »
Judicial Review of the Board’s Decisions and Legal Remedies
Under the Law, the Board has the authority to impose administrative sanctions. It is stipulated that the Board may impose administrative fines for failure to comply with the duty to provide information, obligations relating to data security, failure to comply with decisions issued by the Board, breaches of registration and notification obligations under the Register of Data Controllers, or breaches of the notification obligation regarding standard contracts. In addition to… »
New Pricing Communiqué Following the New Pricing Decision for Medicinal Products for Human Use: Increase of the Euro Conversion Rate to 65% of the Previous Year’s Average and Details of the Pricing Incentive for the First Equivalent/Generic Product
Presidential Decision No. 11031 dated 12 March 2026 (the “New Pricing Decision”) introduced significant changes to the pricing system for medicinal products for human use established under Decision No. 2017/9901 and subsequently amended on several occasions. The New Pricing Decision provided that the provisions of the existing Communiqué on the Pricing of Medicinal Products for Human Use that did not conflict with the New Pricing Decision would continue to apply until a new… »
New Restrictions on Alcohol Advertising: Is Alibi Branding Also Prohibited?
Law No. 7584, which was published in the Official Gazette on 20 June 2026 and entered into force on the same date, introduced significant amendments to the provisions of Law No. 4250 on the Monopoly of Spirits and Alcoholic Beverages concerning the advertising and promotion of alcoholic beverages and the use of brands. The new rules concern support provided by producers, importers and marketers in the alcoholic beverage sector to events, publications and posts; the use of… »
Fixed Exchange Rate in Pricing of Pharmaceuticals and its Impact
The prices of pharmaceuticals to be launched on the market are determined in accordance with the Decision on the Pricing of Medicinal Products for Human Use (“Decision”) and the Communiqué on the Pricing of Medicinal Products for Human Use (“Communiqué”) dated 29 September 2017, published by the Ministry of Health, which has been authorised to regulate this area. The Decision foresees a reference pricing system in which the lowest wholesaler price for the relevant product in… »
IP Court Issues Preliminary Injunction Against Drug in Turkey’s Named Patient Programme
The Istanbul Civil Court for Intellectual and Industrial Rights has granted a preliminary injunction to remove a pharmaceutical product from the foreign drug list of the Turkish Medicines and Medical Devices Agency (TMMDA). The drug was supposed to be supplied via the named patient programme (NPP) and was removed on the grounds of patent infringement. Further, the supplier company has been prevented from directly or indirectly commercialising the product, which includes its… »
Should the Lawyer Follow the Judge’s Misdirection?
Judges represent the state while exercising their judicial power on behalf of the nation. In this respect, it is the principle that the judge, who is expected to be independent first to the state and then to the parties, should be bound only by the rules of law. A thinker has said in this direction, “Judges are both masters and slaves of the law”. A lawyer, on the other hand, is self-employed, but also serves in the public sector as he/she participates in the distribution of… »
Permanent Injunction on the Infringing Pharmaceutical Products on the NPP List
Pharmaceutical products that are not licenced in Turkey and/or licenced but not have been made available to the market can be supplied by Turkish Pharmacists’ Association, Social Security Agency (SSA) and institutions and organizations that are deemed suitable for foreign drug supply by the Turkish Medicines and Medical Devices Agency (“Agency”) (“Foreign Drug Suppliers”) as per to the provisions of the Guideline on Drug Supply and Use from Abroad (“Guideline”). Pursuant to… »
Istanbul IP Court Reaches Landmark Decision on Precautionary Injunction
The trigger point and the timing of a request for a precautionary injunction (PI) is crucial. However, in pharmaceutical patent enforcement, most damage occurs from the launch of the Gx product, which can account for a price cut of as much as 40% from the originator’s drug. Therefore, the PI must be filed and granted before the Gx launches, yet while there is sufficient proof available to overcome the so-called Bolar exemption hurdle. The PI filing date serves this aim… »
A Fairer Way to Determine Royalties in Turkish Compulsory Licensing
Compulsory licensing, which is regulated by both Article 99 of the repealed Decree Law 551 and Article 129 et seq of the Industrial Property Law, which follows Article 31 of the Trade-Related Aspect of Intellectual Property (TRIPs), is a fairly recent institution in Turkey. However, covid-19 has given new urgency to the debate on this issue. Even though it has never actually been applied, compulsory licensing has been widely discussed, not only as a convenient tool to… »
News and Events
We are Attending the ITechLaw 2026 European Conference in Copenhagen
We are pleased to announce our participation in the ITechLaw 2026 European Conference, taking place in Copenhagen from 21–23 October 2026. Our partner, Begüm Yavuzdoğan Okumuş, who leads our Data Protection and Privacy practice, will represent Gün + Partners at the conference with two key contributions: Moderator: Roundtable on "Audit Rights in Practice: How Much Transparency Can Customers Realistically Demand?" Panellist: Panel Discussion “4D: The Implementation of AI…
Gün + Partners Named Law Firm of the Year: Turkey at The Lawyer European Awards 2014
Gün + Partners was named Law Firm of the Year: Turkey at The Lawyer European Awards 2014. We are proud to include this recognition among the milestones in our firm’s history.
Our September 2026 Summer Internship Programme Has Begun
We are pleased to welcome our September 2026 summer interns Zeynep Pelin Çolak, Helin Parsak, Payan Rana Yetkin, Zeynep Göksu Zeybel and Yusuf Eren Karakaya. Throughout the internship programme, they will have the opportunity to work on projects with different practice groups, apply their academic knowledge in legal practice and gain a closer understanding of the professional environment. We wish them a productive and successful internship as they take this important step…
40 Years + One Unforgettable Evening at Lincoln’s Inn
What a magnificent evening! We are still buzzing from the energy at our reception in the Great Hall of Lincoln’s Inn during INTA 2026. It was a true privilege to see this historic hall filled with such a vibrant international community of IP professionals. Hosting our guests within one of the four prestigious Inns of Court—an institution that has stood at the heart of the UK’s legal tradition and the training of barristers for centuries—provided a truly distinguished…
Gün + Partners at the 40th MARQUES Annual Conference in Lisbon
Gün + Partners will participate in the 40th MARQUES Annual Conference, taking place on 22–25 September 2026 at Epic Sana in Lisbon, Portugal. Representing Gün + Partners this year: Mutlu Yıldırım Köse, Partner İrem Girenes Yücesoy, Managing Associate Held under the theme “The Exciting Evolution of Trademarks,” this year’s conference will focus on how trademarks are evolving as businesses explore new ways of using brands and other IP assets to build trust with…
Gün + Partners at the 2026 AIPPI World Congress in Hamburg
We will be attending the 2026 AIPPI World Congress in Hamburg from 7–10 October 2026 and would be pleased to meet with you during the Congress. Representing Gün + Partners this year: Aysel Korkmaz Yatkın, Partner, from our Patents and Utility Models practice. Zeynep Seda Alhas, Partner, from our Trademarks and Designs, Anti-Counterfeiting and Copyright practices. The AIPPI World Congress brings together IP professionals from around the world to discuss current…
Mehmet Gün Recognized in IAM Strategy 300 2026
We are pleased to announce that Mehmet Gün has been recognized in IAM Strategy 300: The World’s Leading IP Strategists 2026. Published annually, IAM Strategy 300 identifies leading professionals in intellectual property strategy, recognizing individuals who develop and implement approaches aimed at realizing and amplifying the value of intellectual property.
Gün + Partners at the IBA Annual Conference 2026 in Copenhagen
We are excited to announce our participation in the upcoming IBA (International Bar Association) Annual Conference in Copenhagen this October, and we warmly invite you to meet with our delegation during the event. Representing Gün + Partners this year: Özge Atılgan Karakulak – Partner | Advisory Board Member of the IBA IP and Entertainment Law Committee; leading our Life Sciences and Patent Litigation practices. Görkem Bilgin – Partner | Leading our Corporate and M&A…
Gün + Partners to Participate in IP.CAMP 2026 as Lead Sponsor
Organized by LES Turkey, IP.CAMP brings together intellectual property professionals, in-house counsel, academics and industry representatives for an intensive programme focused on IP management, licensing, strategy and commercialization. The 2026 edition will take place on 24–26 September 2026 at Boyalık Beach Hotel & SPA in Çeşme, İzmir. This year’s programme will address key topics across the IP landscape, including licensing strategies, IP litigation…
Gün + Partners Participated in the Public Health and Intellectual Property Crimes Workshop in Ankara
On 29–30 July 2026, Gün + Partners participated in the Public Health and Intellectual Property Crimes Workshop organized by the Intellectual Property Rights Department of the Turkish National Police in Ankara.…